Three-part inventions: intracellular signaling and induced proximity.

[1]  Shannon R. Magari,et al.  A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.

[2]  S. Schreiber,et al.  Dimeric ligands define a role for transcriptional activation domains in reinitiation , 1996, Nature.

[3]  S. Schreiber,et al.  Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization , 1996, Current Biology.

[4]  C. Thummel.  From embryogenesis to metamorphosis: The regulation and function of drosophila nuclear receptor superfamily members , 1995, Cell.

[5]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[6]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[7]  G. Orphanides,et al.  Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein. , 1995, Biochemistry.

[8]  T. Hunter,et al.  Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus , 1995, Current Biology.

[9]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[10]  G. Crabtree,et al.  Crystal structure of DCoH, a bifunctional, protein-binding transcriptional coactivator. , 1995, Science.

[11]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[12]  I. Herskowitz.  MAP kinase pathways in yeast: For mating and more , 1995, Cell.

[13]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[14]  D. Wigley.  Structure and mechanism of DNA topoisomerases. , 1995, Annual review of biophysics and biomolecular structure.

[15]  S. Schreiber,et al.  Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. , 1994, Chemistry & biology.

[16]  C. V. Smith,et al.  Crystallization of inhibitor complexes of an N-terminal 24 kDa fragment of the DNA gyrase B protein. , 1994, Journal of molecular biology.

[17]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[18]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[19]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[20]  A. Marks,et al.  Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein , 1994, Cell.

[21]  J. Borel,et al.  Biological effects of cyclosporin A: A new antilymphocytic agent , 1976, Agents and actions.

[22]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[23]  S. Schreiber,et al.  Controlling signal transduction with synthetic ligands. , 1993, Science.

[24]  J. Kunz,et al.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.

[25]  R F Standaert,et al.  Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. , 1993, Journal of molecular biology.

[26]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[27]  G. Crabtree,et al.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.

[28]  G. Crabtree,et al.  Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. , 1991, Science.

[29]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[30]  J. Heitman,et al.  Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.

[31]  C. Klee,et al.  Serine/threonine phosphatases in the nervous system , 1991, Current Opinion in Neurobiology.

[32]  R F Standaert,et al.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.

[33]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[34]  R. Cortese,et al.  A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1 , 1990, Cell.

[35]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[36]  T. Kiefhaber,et al.  Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins , 1989, Nature.

[37]  G. Crabtree,et al.  Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. , 1987, Science.

[38]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[39]  G. Fischer,et al.  The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. , 1985, Biochimica et biophysica acta.

[40]  W. Saenger,et al.  Crystallization of and preliminary X-ray diffraction data for TET-repressor and the TET-repressor-tetracycline complex. , 1984, Journal of Molecular Biology.

[41]  R. Merion,et al.  Cyclosporine: five years' experience in cadaveric renal transplantation. , 1984, The New England journal of medicine.

[42]  G. Kolata.  Drug transforms transplant medicine. , 1983, Science.